BOSCARO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 6.463
EU - Europa 3.393
AS - Asia 1.303
SA - Sud America 203
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 11.411
Nazione #
US - Stati Uniti d'America 6.456
UA - Ucraina 819
IE - Irlanda 398
SG - Singapore 391
RU - Federazione Russa 378
DE - Germania 373
SE - Svezia 347
DK - Danimarca 316
TR - Turchia 306
IT - Italia 264
HK - Hong Kong 215
BR - Brasile 180
FI - Finlandia 180
CN - Cina 170
KR - Corea 167
GB - Regno Unito 136
FR - Francia 114
BE - Belgio 32
CI - Costa d'Avorio 20
IN - India 17
NL - Olanda 9
EC - Ecuador 8
UZ - Uzbekistan 7
AT - Austria 6
EU - Europa 6
CA - Canada 5
CO - Colombia 5
LT - Lituania 5
IQ - Iraq 4
MA - Marocco 4
RO - Romania 4
AR - Argentina 3
AU - Australia 3
BD - Bangladesh 3
CL - Cile 3
IR - Iran 3
JP - Giappone 3
KE - Kenya 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
ZA - Sudafrica 3
BG - Bulgaria 2
DZ - Algeria 2
EG - Egitto 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PL - Polonia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ES - Italia 1
GA - Gabon 1
GE - Georgia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
NP - Nepal 1
PY - Paraguay 1
QA - Qatar 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 11.411
Città #
Chandler 857
Jacksonville 830
Des Moines 706
Boardman 447
Fairfield 423
Dublin 397
Ashburn 350
Wilmington 251
New York 239
Woodbridge 230
Hong Kong 215
Singapore 189
Seattle 180
Ann Arbor 179
Lawrence 168
Princeton 168
Houston 158
Cambridge 145
San Mateo 137
Moscow 100
Centro 64
San Diego 55
The Dalles 36
Los Angeles 33
Brussels 32
Turin 31
Washington 25
Norwalk 23
Abidjan 20
Beijing 20
Civitanova Marche 15
Dallas 15
Falls Church 15
Helsinki 15
São Paulo 14
Guangzhou 12
Shanghai 11
Wuhan 11
Rio de Janeiro 9
London 8
Auburn Hills 7
Mumbai 6
Redmond 6
Rome 6
Tashkent 6
Yiwu 6
Nuremberg 5
Ancona 4
Belo Horizonte 4
Guayaquil 4
Heze 4
Izmir 4
Kilburn 4
Milan 4
Ottawa 4
Salerno 4
São José dos Campos 4
Wuxi 4
Brugherio 3
Filottrano 3
Frankfurt am Main 3
Hortolândia 3
Jiaxing 3
Jinhua 3
Maringá 3
Munich 3
Nairobi 3
Natal 3
New Bedfont 3
Porto Alegre 3
Porto San Giorgio 3
Pune 3
Quanzhou 3
Quito 3
Shenzhen 3
Siena 3
Vienna 3
Ankara 2
Baghdad 2
Belém 2
Bogotá 2
Campinas 2
Cascina 2
Catanzaro 2
Chengdu 2
Copertino 2
Cotia 2
Curitiba 2
Duque de Caxias 2
Edinburgh 2
Fars 2
Hangzhou 2
Hanover 2
Istanbul 2
Itabira 2
Johannesburg 2
Lima 2
Montignoso 2
Muscat 2
Otemae 2
Totale 7.022
Nome #
Persistent psychological distress in patients treated for endocrine disease. 132
Prolactinomas,Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas 130
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 130
Production of peroxynitrite by human spermatozoa and its possible role on sperm motility. 128
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 124
Development of overt Cushing's syndrome in patients with adrenal incidentaloma 115
Adrenal incidentaloma: surgical update. 108
Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women 106
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 103
Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man. 103
Free thiols in human spermatozoa: involvement of Na/K-ATPase and Ca-ATPase activities in sperm motility. 100
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. 97
Multiple endocrine neoplasia type 1 and adrenal lesions 96
Psychosocial impairment in patients treated for pituitary disease: a controlled study 94
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. 94
Diagnosis and complications of Cushing's syndrome: a consensus statement 93
Development of overt Cushing's syndrome in patients with adrenal incidentaloma. 146 (1): 61-66,2002 93
Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas 93
GH secretagogues and hypothalamo-pituitary-adrenal axis 92
Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders. 92
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 91
Cushing's syndrome 90
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 90
Aldosterone as a cardiovascular risk factor. 89
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. 87
Personality characteristics and quality of life in patients treated for Cushing's syndrome 87
Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. 87
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 87
Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. 86
Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. 86
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gps mutations . 86
Adipose cell-adrenal interactions: current knowledge and future perspectives. 85
Correlates of perceived health related quality of life in obese, overweight and normal weight older adults: an observational study 85
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. 84
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 84
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers 82
Coenzyme Q10 and male infertility 81
Sexual symptoms in endocrine diseases: psychosomatic perspectives. 80
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 80
Corticotropin-releasing effect of exarelin, a peptyl GH secretagogue in normal subjects pretreated with metyrapone or RU 486, a glucocorticoid receptor antagonist, and patients with Addison's disease 79
Self image and quality of life in acromegaly 79
Diagnosis and management of adrenal incidentalomas. 79
Effect of glucocorticoids on adiponectin:a study in healthy subjects and Cushing's syndrome 79
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. 78
Genetic mutations in thyroid carcinoma 77
Effects of raloxifene on body fat distribution and lipid profile in healthy post menopausal women 77
Consideration in diagnosis of Cushing's syndrome 77
Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. 77
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 77
Diagnosis of primary aldosteronism: from screening to subtype differentiation 76
Effect of natural early menopause on bone mineral density. 76
Adipose tissue 11 beta-hydrioxysteroid deydrogenase type 1 expression in obesity and Cushing's syndrome 76
Molecolar analysis of CDKN1C and TP53 in sporadic adrenal tumors 76
Obesity and body mass index (BMI) in relation to life-style and psycho-social aspects. 76
Bone health and aldosterone excess 76
A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma. 75
Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase. 75
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 75
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 74
Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. 74
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 74
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 74
Obesity and body mass index (BMI) in ralation to the life style and psycho-social aspects. 73
Left ventricular structure and functional characteristic in Cushing's syndrome 73
Endocrine aspects of cancer gene therapy. 73
Expanding role of AMPK in endocrinology 73
Chemical-physical properties of lipoproteins in anorexia nervosa. 73
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 73
Recovery of Bone Mineral Density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome 72
Effect of the serotonin antagonists ritanserin and ketanserin in Cushing disease 72
Gene therapy for thyroid cancer. 72
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 72
Improvement of sperm cells motility after CoQ10 treatment in infertile males with idiopathic asthenozoospermia. 71
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 71
Oleoylethanolamide protects human sperm cells from oxidation stress: studies on cases of idiopathic infertility 71
In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. 70
Idiopathic infertility: susceptibility of spermatozoa to in vitro capacitation, in the presence and the absence of Palmitylethanolamide (an homologue of Anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. 70
Comment - Is there a role for low doses of mitotane (o, p'-DDD) as adjuvant therapy in adrenocortical carcinoma? 70
Risk factors and long-term follw-up of adrenal incidentalomas. 70
Prevalence and natural history of adrenal incidentalomas. 70
New treatment guidelines on Cushing's disease. 70
Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists 70
Adrenocortical carcinoma:experience in 45 patients. 70
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 69
Adrenal incidentaloma: effects on bone metabolism. 68
Hormonal responses during various phrases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. 68
Chemotherapy at the end of life: an open question. 67
Cortical adrenal mitochondrial morphology changes in functional state: new insights. 67
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 67
The diagnosis of Cushing' s syndrome : atypical presentations and laboratory shortcomings 66
Raloxifene and cadiovascular health: its relationschip to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women 66
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 66
Can the ISO9000 quality assessment be applied to the practice of medical oncology? 66
Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. 66
Anaplastic Thyroid Carcinoma. 66
Brief report: A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma 65
Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma 65
La nutraceutica nell’infertilità maschile. 65
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial 65
Foreword. Glucocorticoid-induced osteoporosis. 64
Totale 8.131
Categoria #
all - tutte 57.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020223 0 0 0 0 0 0 0 0 0 0 6 217
2020/20212.066 86 265 404 22 236 79 223 93 228 115 231 84
2021/20221.131 50 239 9 64 19 93 39 74 82 135 83 244
2022/20232.866 202 221 173 211 217 897 0 183 594 10 114 44
2023/20241.387 254 40 72 233 229 303 18 49 0 32 9 148
2024/20251.570 134 207 123 21 86 57 137 78 567 129 31 0
Totale 11.500